Search results
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 1 week agoGlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies ...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 6 hours agoBourla said in the Q1 call that the company "will make a decision for future plans" after seeing the...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 2 days agoAccording to the Centers for Disease Control and Prevention, as of the end of April this year, just...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life Style via AOL· 2 weeks agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 1 week agoA major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 3 days agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 4 days agoThe drugmaker has faced some big challenges and has more on the way. Pfizer's revenue in 2023 fell...
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 3 days agoDespite a 19% decline in total company revenues to $14.9 billion, primarily due to the reduced...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 2 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 days agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...